ASMB Assembly Biosciences Inc

Price (delayed)

$14.53

Market cap

$80.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$10.48

Enterprise value

$63.3M

Assembly Bio is a clinical-stage biotechnology company committed to bringing finite and curative therapies to the 270 million people living with hepatitis B virus (HBV) worldwide. A pioneer in the ...

Highlights
ASMB's EPS has surged by 52% year-on-year and by 22% since the previous quarter
Assembly Biosciences's net income has increased by 42% YoY and by 16% QoQ
ASMB's quick ratio has dropped by 61% year-on-year and by 12% since the previous quarter
The equity has plunged by 54% YoY and by 21% from the previous quarter

Key stats

What are the main financial stats of ASMB
Market
Shares outstanding
5.51M
Market cap
$80.11M
Enterprise value
$63.3M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.44
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$51.32M
EBITDA
-$50.96M
Free cash flow
$27.56M
Per share
EPS
-$10.48
Free cash flow per share
$5.03
Book value per share
$5.95
Revenue per share
$0
TBVPS
$21.86
Balance sheet
Total assets
$119.88M
Total liabilities
$87.28M
Debt
$1.94M
Equity
$32.6M
Working capital
$78.42M
Liquidity
Debt to equity
0.06
Current ratio
3.02
Quick ratio
2.92
Net debt/EBITDA
0.33
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-54.8%
Return on equity
-120.6%
Return on invested capital
-102.1%
Return on capital employed
-63.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ASMB stock price

How has the Assembly Biosciences stock price performed over time
Intraday
-1.29%
1 week
8.43%
1 month
12.46%
1 year
18.71%
YTD
47.66%
QTD
9.25%

Financial performance

How have Assembly Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$68.76M
Net income
-$51.36M
Gross margin
N/A
Net margin
N/A
Assembly Biosciences's net income has increased by 42% YoY and by 16% QoQ
Assembly Biosciences's operating income has increased by 24% YoY and by 4.2% QoQ

Growth

What is Assembly Biosciences's growth rate over time

Valuation

What is Assembly Biosciences stock price valuation
P/E
N/A
P/B
2.44
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ASMB's EPS has surged by 52% year-on-year and by 22% since the previous quarter
The price to book (P/B) is 88% higher than the 5-year quarterly average of 1.3 and 74% higher than the last 4 quarters average of 1.4
The equity has plunged by 54% YoY and by 21% from the previous quarter

Efficiency

How efficient is Assembly Biosciences business performance
The ROIC has increased by 38% YoY and by 29% from the previous quarter
The company's return on assets rose by 31% YoY and by 24% QoQ
The return on equity has declined by 29% year-on-year and by 2.5% since the previous quarter

Dividends

What is ASMB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ASMB.

Financial health

How did Assembly Biosciences financials performed over time
The total assets is 37% more than the total liabilities
Assembly Biosciences's current ratio has shrunk by 62% YoY and by 11% QoQ
ASMB's quick ratio has dropped by 61% year-on-year and by 12% since the previous quarter
The company's debt is 94% lower than its equity
The equity has plunged by 54% YoY and by 21% from the previous quarter
The debt to equity has soared by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.